Talazoparib Plus Enzalutamide After Progression to Abiraterone in Metastatic Prostate Cancer: (TEAM PC)

Clinical trial NCT06582628 · RECRUITING

Trial details

NCT number: NCT06582628
Sponsor: Fundacion Oncosur
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Metastatic Prostate Cancer

Start date: 2024-07-05
Primary completion: 2026-01-31
Enrollment: 78

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.